Business
from24/7 Wall St.
3 days agoWhy Barclays Thinks Ionis Is Headed for a 45% Surge From $73 to $106
Ionis Pharmaceuticals has seen significant stock performance, with Barclays predicting a price target of $106 based on the potential of its sHTG treatment.